May 3, 2013
- A study led by prominent breast cancer experts from Europe and the US has revealed a number of potentially important prospects for targeted therapies, and brings opportunities of truly personalised therapy for breast cancer a step closer, researchers said at the 5th IMPAKT Breast Cancer Conference in Brussels, Belgium. The IMPAKT meeting presents cutting edge, 'translational' breast cancer research that is beginning to have an impact for patients....
May 2, 2013
Following the recent recommendation by the Pharmacovigilance Risk Assessment Committee (PRAC), the Co-ordination Group for Mutual Recognition and Decentralised Procedures - Human (CMDh) has endorsed by majority the PRAC recommendation to suspend the marketing authorisations of tetrazepam-containing medicines across the...
April 30, 2013
- Research to set up an online system enabling doctors to access patient's health records from all across the European Union, has been launched. The University of Bedfordshire is leading the European Commission project, MyHealthAvatar, which is designed to give people more knowledge and control of their health via their computers and mobile phones. The programme will keep archives of each user's electronic health records, as well as store data about daily activities and family history. These...
- 25 - 28 May 2013, Lisbon, Portugal.
The Heart Failure Congress 2013 promises more science than ever this year, with a record number of abstracts submitted. More than 1,500 scientific abstracts from around the globe will be presented. The top ranking abstracts will be presented orally and a large area will be dedicated to poster presentations. Flash presentations with research highlights will be followed by animated discussions led by international leaders in heart failure,...
April 29, 2013
- For the first time, researchers at Karolinska Institutet in Sweden have managed to obtain detailed images of the way in which the transport protein GLUT transports sugars into cells. Since tumours are highly dependent on the transportation of nutrients in order to be able to grow rapidly, the researchers are hoping that the study published in the scientific magazine Nature Structural & Molecular Biology will form the basis for new strategies to fight cancer cells. In order to be able to...
April 26, 2013
- A practical guide on the use of the new oral anticoagulants (NOACs) has been produced by the European Heart Rhythm Association (EHRA) of the European Society of Cardiology (ESC). A guide was needed to summarise existing information on different drugs, to answer clinical questions that fall outside what drug companies can legally answer, and to make distinctions between the different drugs. ESC guidelines on atrial fibrillation recommend the NOACs as preferable to vitamin K antagonists for...
April 25, 2013
- 18 - 19 September 2013, London, United Kingdom.
2013 has presented a unique set of challenges to the pharmaceutical industry. Transparency is becoming ever more prevalent in all aspects of the regulatory process, regulatory bodies are sanctioning drug companies unlike ever before, competitors are using new strategies to gain possession of your best-kept secrets, the impact of technology continues to grow, and new legislation is coming into force which will alter the playing field...
April 24, 2013
- Concerns have been raised in the media about certain stem cell therapy treatments. These sorts of new techniques potentially offer exciting possibilities to patients for the treatment of a range of difficult or previously untreatable conditions. Like all treatments, these techniques also come with benefits and risks....
April 23, 2013
- 30 September - 1 October 2013, Odense, Denmark.
Denmark will over the next ten years, spend € 5.5 billion on the construction of eight new super hospitals, including the new Odense University Hospital (OUH). Region Southern Denmark is therefore inviting international stakeholders from the public and private sector to meet and discuss how to ensure sustainable future health care solutions through innovative private and public partnerships. The congress "Hospital + Innovation...
April 22, 2013
- Unavoidable damage caused to the heart and lungs by radiotherapy treatment of tumours in the chest region can be limited by the administration of an ACE inhibitor, a drug commonly used in the treatment of cardiovascular disease, a group of Dutch researchers have found.[1] Common cancers such as breast, oesophagus, lung, and Hodgkin's lymphoma are frequently treated with radiotherapy, but the radiation dose that can be given safely is limited by the sensitivity of the health lung tissue which is...